Table 2.
Years of Follow-Up | Burch (n316,670) | Sling (n3127,848) | Bulking Agents (n34,159) | Laparoscopic (n33,754) | TVH (n31,473) | Needle (n31,110) | Kelly Plication (n3444) |
---|---|---|---|---|---|---|---|
1 | 4.4 (4.1–4.7) | 5.4 (5.2–5.5) | 34.0 (32.4–35.6) | 5.5 (4.7–6.2) | 4.8 (3.7–5.9) | 7.0 (5.4–8.5) | 4.6 (2.5–6.7) |
2 | 5.3 (4.9–5.7) | 6.4 (6.3–6.6) | 42.1 (40.2–43.9) | 6.8 (5.9–7.7) | 6.0 (4.6–7.3) | 9.0 (7.1–10.9) | 6.3 (3.5–9.1) |
3 | 6.1 (5.7–6.6) | 7.3 (7.1–7.4) | 46.9 (44.9–49.0) | 7.7 (6.7–8.8) | 6.6 (5.2–8.1) | 10.2 (8.1–12.2) | 8.5 (4.8–12.2) |
4 | 7.0 (6.5–7.5) | 8.2 (7.9–8.4) | 51.1 (48.7–53.5) | 9.0 (7.7–10.3) | 6.9 (5.3–8.4) | 11.4 (9.0–13.8) | 9.6 (5.4–13.9) |
5 | 7.7 (7.2–8.3) | 9.0 (8.7–9.3) | 54.6 (51.8–57.3) | 10.0 (8.5–11.6) | 9.2 (6.9–11.4) | 14.1 (11.0–17.3) | 11.3 (6.0–16.5) |
6 | 8.8 (8.1–9.5) | 9.8 (9.4–10.2) | 54.6 (51.8–57.3) | 10.4 (8.7–12.0) | 9.9 (7.5–12.4) | 16.6 (12.7–20.5) | 11.3 (6.0–16.5) |
7 | 9.3 (8.5–10.0) | 10.6 (10.1–11.1) | 57.3 (53.9–60.6) | 11.8 (9.5–14.0) | 10.5 (7.8–13.2) | 22.2 (16.5–27.9) | NR |
8 | 9.9 (8.9–10.8) | 12.2 (11.2–13.2) | 61.2 (56.3–66.0) | 13.3 (10.2–16.4) | 13.0 (8.6–17.3) | 22.2 (16.5–27.9) | NR |
9 | 10.8 (9.3–12.3) | 13.0 (11.7–14.3) | NR | 16.9 (9.4–24.5) | NR | NR | NR |
TVH, total vaginal hysterectomy and colpo-urethrocystopexy; NR, not reported for time points where 20 or fewer individuals remained in follow-up.